FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
21/05/2024
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Snapshot rápido
MICROCYCLES
ST13
US500000079345480Classe
Pedido
Registro
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Tipo de processo
Eventos registrados
Atualização mais recente
Classificação
Tipo de marca
Classes Nice
Data de depósito
Data de registro
Data de expiração
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
Última transação
Escritório responsável
Código da situação
Cadastro oficial
Código do desenho
Tipo de titular
Localização do titular
Examinador
Unidade examinadora
Localização atual
Titulares
Representantes
Bruce S. Londa Norris McLaughlin, P.A.
Classes Nice
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 1
Chemicals for use in biotechnological product development; chemicals for use in biotechnological manufacturing processes; chemical preparations in the nature of biologically compatible chemical substances for scientific purposes other than for medical or veterinary use, namely, scientific, laboratory, clinical and medical research; biological tissue, namely, mammalian soft and hard tissues comprising or derived from stem cells or progenitor cells for scientific, laboratory, clinical and medical research; biological tissue, namely, biological tissue comprising or derived from stem cells or progenitor cells, and compositions thereof, for scientific, laboratory, clinical and medical research
Classe 5
Pharmaceutical preparations for cancer and neurological diseases for medical and veterinary use; sanitary preparations for medical purposes; dietetic food and substances adapted for medical or veterinary use; dietary supplements for human beings and animals; dietary supplements; pharmaceutical preparations for use in oncology
Classe 42
Drug discovery and pharmaceutical drug development services; scientific services, namely, research in the field of pharmaceuticals, and new product development and design relating thereto; medical research; technological services, namely, research in the field of pharmaceuticals, and new product design relating thereto; new product design and development of medical technology; new product design and development of medical diagnostic apparatus; consultancy services relating to development of new technology for others in the field of pharmaceuticals and medical technology; industrial analysis, namely, consulting services in the field of industrial engineering; industrial research in the field of pharmaceuticals and medical technology; design and development of computer hardware and software; clinical research in the field of antibodies, immuno-oncology, inflammation, haematology and infectious disease; pharmaceutical research and development; development of pharmaceutical preparations and medicines; research and development services in the field of antibodies, immuno-oncology, inflammation, haematology and infectious disease; scientific research in the nature of conducting clinical trials for others; scientific research in the nature of conducting clinical trials for pharmaceutical products; scientific screening and assaying in the nature of providing reagent sample testing and diagnostic services for others for scientific research purposes; chemical analysis; chemical research; biotechnology research; consultancy relating to biotechnology
Classe 44
Medical services; medical diagnostic testing services and prognostic medical services in the nature of medical consultations; veterinary services; medical analysis services relating to the treatment of persons; pharmaceutical advice; medical and health counseling services relating to antibodies, immuno-oncology, inflammation, haematology and infectious disease; medical screening and assaying in the nature of medical testing for diagnostic or treatment purposes
Histórico de despachos e eventos da marca no USPTO.
36 publicações encontradas
FINAL DECISION TRANSACTION PROCESSED BY IB
21/05/2024
FINAL DISPOSITION NOTICE SENT TO IB
01/05/2024
FINAL DISPOSITION PROCESSED
01/05/2024
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
30/04/2024
NOTICE OF REGISTRATION CONFIRMATION EMAILED
30/01/2024
REGISTERED-PRINCIPAL REGISTER
30/01/2024
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
13/01/2024
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
27/12/2023
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
27/12/2023
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
14/11/2023
PUBLISHED FOR OPPOSITION
14/11/2023
NOTIFICATION PROCESSED BY IB
13/11/2023
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
25/10/2023
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
25/10/2023
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
25/10/2023
APPROVED FOR PUB - PRINCIPAL REGISTER
12/10/2023
TEAS/EMAIL CORRESPONDENCE ENTERED
11/10/2023
CORRESPONDENCE RECEIVED IN LAW OFFICE
11/10/2023
TEAS REQUEST FOR RECONSIDERATION RECEIVED
11/10/2023
NOTIFICATION OF FINAL REFUSAL EMAILED
10/09/2023
FINAL REFUSAL E-MAILED
10/09/2023
FINAL REFUSAL WRITTEN
10/09/2023
TEAS/EMAIL CORRESPONDENCE ENTERED
09/08/2023
CORRESPONDENCE RECEIVED IN LAW OFFICE
09/08/2023
TEAS RESPONSE TO OFFICE ACTION RECEIVED
09/08/2023
NEW REPRESENTATIVE AT IB RECEIVED
02/04/2023
REFUSAL PROCESSED BY IB
06/03/2023
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
14/02/2023
REFUSAL PROCESSED BY MPU
14/02/2023
NEW REPRESENTATIVE AT IB RECEIVED
29/01/2023
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
17/12/2022
NON-FINAL ACTION WRITTEN
16/12/2022
ASSIGNED TO EXAMINER
09/12/2022
APPLICATION FILING RECEIPT MAILED
26/07/2022
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
22/07/2022
SN ASSIGNED FOR SECT 66A APPL FROM IB
21/07/2022
Proteção contínua da sua marca
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.